What Doctronic does
Doctronic offers a conversational AI health assistant that provides free, anonymous symptom assessment, potential diagnoses, and action plans, then connects users who need it to board-certified physicians for a paid video visit. The company says it is licensed to practice medicine in all 50 US states and, per Stat News, became the first AI in the US legally permitted to renew prescriptions after a 2025 pilot in Utah's AI Learning Lab regulatory sandbox. Doctronic reports 99.2% physician alignment on its assessments and says revenue grew 15x in the six months after its 2025 Series A. The company was founded in 2022 and is headquartered in New York.
Doctronic is a healthcare tool on Falcoscan. AI doctor offering free symptom checks and paid video visits with licensed physicians. Falcoscan rates Doctronic with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Doctronic is founded in 2022, currently at Series_b stage. Pricing: Freemium.